Yugalinks

T13 · Trade opportunity evidence

United Kingdom (GBR) to Cyprus (CYP) medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300431)

A country-to-country view of reported medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale trade, combining buyer demand, exporter position, market structure, access conditions, and observed lane history.

Exporter United Kingdom (GBR)Importer Cyprus (CYP)HS6 300431One-way tradeCoverage 2000-2020Slowing
Explore this product

3-year buyer projection

$12.5MCalculated from reported demand

Exporter growth

-4.1%Full available history

Suppliers in market

7Latest reported count

Observed history

21 yearsLast year: 2020

Reported observations

What this medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale lane shows for HS 300431

Core values for United Kingdom (GBR) → Cyprus (CYP) in HS 300431.

Buyer market

Latest imports$8.9M
Five-year projection$15.6M
Buyer CAGR+11.8%
Latest annual change+2.3%

Exporter position

Latest exports$2.0K
Market share0.1%
Share change+0.1 pp
Best observed share92.9%

Market structure

Reported suppliers7
Concentration index8,665.7
Share gap+92.8 pp
SignalSlowing

Detailed evidence

Complete lane evidence

Reported values, calculated indicators, and country-pair context for this route.

MeasureValueWhat it describes
Buyer imports$8.9MCyprus (CYP)'s latest reported imports
Exporter exports$2.0KUnited Kingdom (GBR)'s exports to Cyprus (CYP)
Exporter market share0.1%Exporter share of the reported buyer market
Buyer five-year CAGR+11.8%Annualized change in buyer imports
Exporter full-history CAGR-4.1%Annualized change in exporter exports
Three-year buyer projection$12.5MCalculated projection from reported demand
Five-year buyer projection$15.6MCalculated projection from reported demand
Average buyer imports$2.4MAverage reported importer value
Peak buyer imports$8.9MHighest reported importer value
Average exporter exports$6.6KAverage reported lane exports
Peak exporter exports$40.1KHighest reported lane exports
Share change+0.1 ppLatest one-year change in exporter share
Reported suppliers7Supplier countries observed in the latest period
Buyer GDP$27.7BLatest buyer-country GDP estimate
Buyer GDP per person$22.8KLatest buyer-country GDP per person
Buyer population1,215.6 thousandLatest buyer-country population estimate
Buyer investment rate20.3%Reported buyer-country investment rate
Buyer secondary education93.2%Reported secondary education coverage
Distance3,224 kmApproximate country-pair distance
Business entry time6 daysReported days to start a business
Shared legal systemYesCountry-pair institutional relationship
Reported FTAYesReported trade-agreement indicator
WTO memberYesBuyer-country WTO membership indicator
Lane volatility1.7Variation indicator across observed lane values
Maximum drawdown100%Largest observed decline from a prior peak
Observed history21 yearsCoverage through 2020

Research reading

Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale demand and the United Kingdom (GBR) to Cyprus (CYP) lane

Cyprus (CYP) reported $8.9M of medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale imports in 2020. United Kingdom (GBR) accounted for 0.1% of the observed market and reported $2.0K in exports on this lane.

The latest annual values eased slightly, while the longer available history shows +11.8% buyer growth and -4.1% exporter growth. The page separates reported values from projections and indicators.

Product classification

What does HS 300431 include?

HS 300431 covers Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale. This page studies the six-digit Harmonized System classification rather than a company, brand, retail category, or individual shipment.

The classification sits in HS chapter 30 and heading 3004. The recorded trade type is one-way trade, with a high price range classification in the available product reference data.

How to interpret this page

Compare demand, position, and history together

This HS 300431 trade opportunity page brings together the buyer market in Cyprus (CYP), the exporter position of United Kingdom (GBR), and the observed conditions of their trade lane. A large buyer market does not by itself show that every exporter has equal access, and a positive growth rate does not remove the need to examine volatility and historical coverage.

Use the reported imports and exports to understand scale, market share to understand position, projections to understand the calculated forward view, and lane history to understand how much evidence supports the comparison.

Frequently asked questions

Questions about United Kingdom (GBR) to Cyprus (CYP) medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale trade

What is the HS code for this product?

This page covers HS 300431, the six-digit product classification shown in the trade records.

How large is the Cyprus (CYP) market?

The page reports the latest buyer imports, historical averages, peaks, growth, and calculated projections for medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale.

How strong is United Kingdom (GBR) in this market?

Exporter performance is shown through lane exports, market share, share change, growth, and the number of reported suppliers.

What should be checked before entering this market?

Review market scale, competition, access indicators, volatility, drawdown, and the available history together rather than relying on one signal.

Continue your researchHS 300431 product overviewExplore this product in the workspaceMethodology and definitions

Definitions and coverage

How to read this page

Reported values

Trade values describe reported merchandise trade for the stated HS6 classification. They are not company-level sales or shipment records.

Calculated indicators

Growth, projections, concentration, volatility, and share-gap figures are calculated from the reported observations and should be interpreted with their coverage period.

Coverage

This sample covers 21 observed years through 2020. Missing values are shown as not reported rather than estimated.

Explore the classification

Compare this product across markets and routes

Use the trade data and methodology pages to study other exporters, importers, and HS6 products.